Homeschool team wins state Science Olympiad Tournament
The Science Olympiad is a nationwide STEM competition, providing standards-based challenges to 6,600 teams at 425 tournaments in all 50 states. This latest competition was on April 5 at the University of Colorado Colorado Springs (UCCS), and Homeschool Science Colorado took home the gold.
'I feel ecstatic about it,' said Lydia Wickerham, who is in Division C of the Science Olympiad. 'None of us were really expecting it this year.'
Cindy Puhek, head coach of the homeschool team, said the teams won the tournament against 30 other teams in each division that represented schools from all across the state. This is the third time the high school division has won the title, but the first time for the middle school division since 2021.
'It really is teamwork,' Puhek said. 'You have to do well across all 23 events to win, so you have to have everybody committed.'
While most students are already accustomed to deadlines and working with others, Puhek said this is a challenge that homeschool students in general must overcome.
'Having hard and set deadlines, because within homeschool, sometimes we can let things slide, but a tournament is a tournament and that deadline is hard and fast,' Puhek said. 'The soft skills, being able to work as part of a team and work with partners, I think, is critical.'
The students said they have created not only friendships to last a lifetime, but built those skills to give them a leg-up in life as well.
'Meeting new people, creating a network of young scientists and preparing me for my future in college,' Wickerham said.
Homeschool Science Colorado will represent the state of Colorado at the National Science Olympiad Tournament at the University of Nebraska-Lincoln on May 23-24.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31-07-2025
- Yahoo
Common Viruses May Wake Dormant Breast Cancer Cells, Study Finds
Breast cancer patients who have been in remission for years or even decades may still need to be cautious about respiratory infections. Some common viruses may re-awaken a very small number of dormant breast cancer cells within our lungs, according to emerging research. "Dormant cancer cells are like the embers left in an abandoned campfire, and respiratory viruses are like a strong wind that reignites the flames," argues molecular geneticist James DeGregori from the University of Colorado. Related: The research began following the COVID-19 pandemic, when DeGregori and his colleagues began to notice a curious uptick in cancer cases. To find out more, the international team turned to human population studies and mouse models. They found that patients in remission for cancer in the UK Biobank who tested positive for SARS-CoV-2 later showed a twofold increase in cancer-related death. "The extent of this increased risk is almost unheard of in epidemiology for cancer," says epidemiologist Roel Vermeulen from Utrecht University in The Netherlands. "It's a significant effect." That's not all researchers found, either. Analyzing a separate breast cancer database from the United States, including nearly 37,000 patients, they discovered that a previous SARS-CoV-2 infection was associated with a greater than 40 percent increased risk of metastatic breast cancer in the lungs. Studies in mice suggest that viruses might be behind the spread. Influenza and SARS-CoV-2 infections triggered dormant breast cancer cells in mice to proliferate after only days of infection. Within two weeks, there was "a massive expansion of carcinoma cells into metastatic lesions" by more than 100-fold, write the authors, led by molecular geneticist Shi Chia from the University of Colorado. "Although species differences warrant caution in interpreting mouse data… collectively, these findings underscore the substantial metastatic risk COVID-19 posed to cancer survivors," warn the team. For years now, scientists have suspected that some highly common viruses, like the Epstein-Barr Virus (EBV), have the potential to trigger certain cancers. The human papillomavirus (HPV) is already known to do this. That's why the HPV vaccine has proved so life-changing for millions. It prevents deadly, viral-associated diseases, like cervical cancer. Since 1936, scientists have been searching for a virus that triggers breast cancer in a similar way, mostly in mice and human population studies. High-risk viruses have been detected in human breast cancer samples. EBV, for instance, is five times higher in breast cancer tissue than in normal tissue. But while the idea that viruses may predispose us to cancer is plausible, research in human cells is limited, and the mechanism underlying the disease spread remains undetermined. The immune system's response to viruses could possibly play a role. After initial remission, a tiny number of breast cancer cells can remain dormant in lung, bone, and liver tissue. Sometimes, inflammation can wake these cancer cells up – and viral respiratory infections, like the flu and COVID-19, can cause inflammation. In the current mouse experiments, the influenza A virus only reawakened dormant cancer cells in the lung if they triggered an increase in inflammatory cytokines, such as IL-6. The same was true of the coronavirus. The findings suggest that the immune system's response to viruses breeds the perfect environment for cancer to proliferate. "What our data suggest is that if you are a cancer patient who has these dormant cells, you may end up living a normal life and dying with these dormant cells, instead of dying because those dormant cells awakened," says DeGregori. "But if you get a respiratory virus like influenza or COVID, your chance of dying from those dormant cells awakening is much greater." If that's true, then it will be vital to protect the millions of breast cancer survivors out there who may face an increased risk of relapse if they get sick. Further research is needed to see if vaccination against influenza or COVID-19 can help. The study was published in Nature. Related News Study Reveals The Shocking Amount of Plastic We Breathe in Every Day Researchers Identified New Blood Group After 50 Year Mystery Sleepiness Could Be Triggered by a Power Overload in Our Brain Solve the daily Crossword
Newsweek
30-07-2025
- Newsweek
Respiratory Viruses Risk Waking Dormant Cancer
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Respiratory infections like COVID-19 and the flu may increase the risk of dormant breast cancer cells reactivating and spreading in those with a history of the disease. This is the conclusion of a study based on experiments with mice and observational human health data by researchers at the University of Colorado, the Montefiore Einstein Comprehensive Cancer Center (MECCC) in New York and Utrecht University. Such an awakening, the team warn, could trigger new metastatic tumors. "Dormant cancer cells are like the embers left in an abandoned campfire—and respiratory viruses are like a strong wind that reignites the flames," said paper author James DeGregori of the University of Colorado Cancer Center in a statement. The findings highlight the need for patients to be aware of the risk between infection and cancer spread. For affected patients, "The simplest strategy would be to avoid infection (vaccination, avoiding crowded places during flu season, etc)," DeGregori told Newsweek. An illustration of cancer cells marked with green, and the proliferation of cells marked in magenta. An illustration of cancer cells marked with green, and the proliferation of cells marked in magenta. Michael DeGregori Breast cancer is the most common cancer in women. Around 316,950 new cases of invasive breast cancer will be diagnosed in women in the U.S. this year, with more than 42,000 women expected to die from the disease this year alone, according to the American Cancer Society. After remission, cancer cells may remain dormant for years before spreading— notably in the lungs or other organs—and causing a relapse. As viral respiratory infections like SARS-CoV-2 (the virus that causes COVID-19) are associated with inflammation, this may trigger processes that could cause cancer cells to spread. A rise in cancer death rates in the first two years of the pandemic led DeGregori and his colleagues to study the effects of the influenza virus and SARS-CoV-2 infections on breast cancer outcomes in mouse models. They determined that these infections reduced the dormancy of breast cancer cells in the lungs. The cancer cells multiplied within days of infection, leading to the expansion of metastatic cancer lesions within two weeks. Inflammatory pathways are implicated in this effect, the researchers found. "The study proves that the general phenomenon can also be observed in humans. Of course, the authors cannot prove that it is the same mechanism, as these are epidemiological data," said professor Carsten Watzl, Scientific Director of the Immunology Research Unit of the Leibniz Research Centre for Working Environment and Human Factors Dortmund. An image showing the awakening of dormant cancer cells. An image showing the awakening of dormant cancer cells. Bryan Johnson Analysis of molecules revealed that the awakening of dormant cancer cells is driven by a protein called interleukin-6 (IL-6), which immune cells release in response to infections or injuries. "The identification of IL-6 as a key mediator in arousing DCCs from dormancy suggests that using IL-6 inhibitors or other targeted immunotherapies might prevent or lessen the resurgence of metastasis following viral infection," said paper author and MECCC cell biologist Julio Aguirre-Ghiso said in a statement. The researchers also examined whether patients with cancer that tested positive for COVID-19 might have an increased risk of cancer-related death, analyzing data from the UK Biobank (4,837 participants, all cancer types) and Flatiron Health (36,845 patients with breast cancer) databases. They discovered an association between SARS-CoV-2 infection and risk of death in the Biobank group. Patients that tested positive SARS-CoV-2 showed a twofold increase in cancer-related death compared to those who were negative. In the Flatiron group, the infection was associated with an increase of more than 40 percent in the risk of metastatic disease in the lungs. It should be noted the new study focused on the period before COVID-19 vaccines were available. Although the studies were limited to those previously diagnosed with cancer, or mice that had dormant cells already when infected, DeGregori cautioned that the team, "couldn't rule out an effect on those with active cancer." Cell and molecular biologist John Alcorn of the University of Pittsburg told Newsweek, "This study does not address how bad of a COVID or flu infection is needed to trigger this type of response. Another prevention would be to have imaging done if you are a cancer patient in remission who gets a viral pneumonia. This could lead to early detection or resurgence and increased treatment options." DeGregori added: "Additional research and clinical studies will be needed for the development of interventions that could be applied during the infection, and we are actively working to develop such interventions." The researchers plan to extend their analyses, both in animal models and of clinical data, to other cancer types and areas of metastatic disease. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about breast cancer? Let us know via health@ Reference Chia, S. B., Johnson, B. J., Hu, J., Valença-Pereira, F., Chadeau-Hyam, M., Guntoro, F., Montgomery, H., Boorgula, M. P., Sreekanth, V., Goodspeed, A., Davenport, B., De Dominici, M., Zaberezhnyy, V., Schleicher, W. E., Gao, D., Cadar, A. N., Petriz-Otaño, L., Papanicolaou, M., Beheshti, A., Baylin, S. B., ... DeGregori, J. (2025). Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature.
Yahoo
22-07-2025
- Yahoo
Time to be redefined as scientists design most accurate clock ever
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways Possibly originating with the English poet Geoffrey Chaucer's "time and tide wait for no man," the idea that time waits for no man has been around for a long time. But time, or at least the latest best measurement of it, has waited 20 years for the latest "most accurate" clock ever made - an ion or atomic "quantum logic" timepiece that measures to the 19th decimal place, making the priciest wristwatch seem like a sundial in comparison. In work published in the journal Physical Review, developers based at the US National Institute of Science and Technology (NIST) said the device uses quantum computing techniques to "pair an electrically charged aluminium atom (ion) with a magnesium ion." NIST claimed the new clock to have accuracy "41% greater than the previous record" and to show "a threefold reduction in instability" compared to the previous best atomic clocks. The previous record-holder, developed by NIST and the University of Colorado Boulder, could "detect the effects of gravity predicted by the theory of general relativity at the microscopic scale," NIST said in 2024. The record-busting new clock has been "under continuous development for 20 years," according to NIST, which said the work would help define the second more accurately, a development it believes could herald "new scientific and technological advances." The new clock's ticks are more stable than those of caesium, the provider of the current scientific definition of the second, according to NIST's David Hume. Hume's colleague Mason Marshall believes that fine-tuning the measurement of time "can push the field of physics and our understanding of the world around us." Listed since 1960 as "an international standard unit of measurement for time," the second was at first defined or measured by the rotation of the Earth relative to the cosmos. But because that rotation can slow down and speed up depending on factors such as the pull of the Moon - posing "a challenge for accurate timekeeping," according to NIST - the definition was changed in 1967 to one based on energy levels in atoms. Another redefinition is likely over the coming decade, NIST said in 2023.
